Receptor-interacting protein 2 is a marker for resolution of peritoneal dialysis-associated peritonitis

Kidney International

Volumn 72, Issue 10, 2007, Pages 1273-1281

  McCully, M L ^a   Baroja, M L ^a   Chau, T A ^a   Jain, A K ^a,b   Barra, L ^a,b   Salgado, A ^a   Blake, P G ^a,b   Madrenas, J ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Bacterial; Cell activation; Human; Inflammation; Protein kinase

Indexed keywords

BACTERIAL TOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RECEPTOR INTERACTING PROTEIN 2; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CELL ACTIVATION; CELL STRAIN HEK293; CELL STRAIN HL 60; CELL STRAIN U937; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEUKEMIA CELL LINE; MALE; MYCOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEAL DIALYSIS; PERITONITIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REMISSION; TH1 CELL; UPREGULATION;

EID: 35848958172     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002534     Document Type: Article

References (50)

1. Dong C, Flavell RA. Th1 and Th2 cells. Curr Opin Hematol 2001; 8: 47-51.
2. Santana MA, Rosenstein Y. What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J Cell Physiol 2003; 195: 392-401.
3. Dasgupta MK, Larabie M, Halloran PF. Interferon-gamma levels in peritoneal dialysis effluents: relation to peritonitis. Kidney Int 1994; 46: 475-481.
4. Koziol-Montewka M, Ksiazek A, Janicka L et al. Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD). Inflamm Res 1997; 46: 132-136.
5. Wang HH, Lin CY. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response. Am J Kidney Dis 2005; 46: 328-338.
6. Krishnan M, Thodis E, Ikonomopoulos D et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002; 22: 573-581.
7. Inohara N, del Peso L, Koseki T et al. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J Biol Chem 1998; 273: 12296-12300.
8. McCarthy JV, Ni J, Dixit VM. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem 1998; 273: 16968-16975.
9. Thome M, Hofmann K, Burns K et al. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol 1998; 8: 885-888.
10. Bouchier-Hayes L, Martin SJ. CARD games in apoptosis and immunity. EMBO Rep 2002; 3: 616-621.
11. Sarkar A, Duncan M, Hart J et al. ASC directs NF-{kappa}B activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. J Immunol 2006; 176: 4979-4986.
12. Zhang WH, Wang X, Narayanan M et al. Fundamental role of the Rip2/ caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc Natl Acad Sci USA 2003; 100: 16012-16017.
13. Munz B, Hildt E, Springer ML et al. RIP2, a checkpoint in myogenic differentiation. Mol Cell Biol 2002; 22: 5879-5886.
14. Kobayashi K, Inohara N, Hernandez LD et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002; 416: 194-199.
15. Chin AI, Dempsey PW, Bruhn K et al. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 2002; 416: 190-194.
16. Yu PW, Huang BC, Shen M et al. Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr Biol 1999; 9: 539-542.
17. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995.
18. McCully ML, Chau TA, Luke P et al. Characterization of human peritoneal dendritic cell precursors and their involvement in peritonitis. Clin Exp Immunol 2005; 139: 513-525.
19. Biron CA, Gazzinelli RT. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr Opin Immunol 1995; 7: 485-496.
20. + T cells. J Immunol 1995; 154: 5071-5079.
21. Wolf SF, Temple PA, Kobayashi M et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991; 146: 3074-3081.
22. Beutler B, Hoebe K, Du X et al. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003; 74: 479-485.
23. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260.
24. Chow JC, Young DW, Golenbock DT et al. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-10692.
25. Jamieson C, McCaffrey PG, Rao A et al. Physiologic activation of T cells via the T cell receptor induces NF-kappa B. J Immunol 1991; 147: 416-420.
26. Ogura Y, Inohara N, Benito A et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001; 276: 4812-4818.
27. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749-759.
28. Lu C, Wang A, Dorsch M et al. Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity. J Biol Chem 2005; 280: 16278-16283.
29. Abbott DW, Wilkins A, Asara JM et al. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol 2004; 14: 2217-2227.
30. Ruefli-Brasse AA, Lee WP, Hurst S et al. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation. J Biol Chem 2004; 279: 1570-1574.
31. Li L, Bin LH, Li F et al. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways. J Cell Sci 2005; 118: 555-563.
32. Navas TA, Baldwin DT, Stewart TA. RIP2 is a Raf1-activated mitogen-activated protein kinase kinase. J Biol Chem 1999; 274: 33684-33690.
33. Stehlik C, Hayashi H, Pio F et al. CARD6 is a modulator of NF-kappa B activation by Nod1- and Cardiak-mediated pathways. J Biol Chem 2003; 278: 31941-31949.
34. Chen CM, Gong Y, Zhang M et al. Reciprocal cross-talk between Nod2 and TAK1 signaling pathways. J Biol Chem 2004; 279: 25876-25882.
35. Dufner A, Pownall S, Mak TW. Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation. Proc Natl Acad Sci USA 2006; 103: 988-993.
36. Mariathasan S, Newton K, Monack DM et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004; 430: 213-218.
37. Goriely S, Molle C, Nguyen M et al. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 2006; 107: 1078-1084.
38. Eickhoff J, Hanke M, Stein-Gerlach M et al. RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response. J Biol Chem 2004; 279: 9642-9652.
39. Chiesa S, Vigo G, Cappa F et al. Peritoneal T cell responses can be polarized toward Th1 or Th2 in children on chronic peritoneal dialysis. Artif Organs 2004; 28: 750-752.
40. Cameron JS. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis. Pediatr Nephrol 1995; 9: 647-662.
41. McLoughlin RM, Witowski J, Robson RL et al. Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 2003; 112: 598-607.
42. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003; 300: 337-339.
43. Valle MT, Degl'Innocenti ML, Bertelli R et al. Antigen-presenting function of human peritoneum mesothelial cells. Clin Exp Immunol 1995; 101: 172-176.
44. Burns KA, Martinon F. Inflammatory diseases: is ubiquitinated NEMO at the hub? Curr Biol 2004; 14: R1040-R1042.
45. Watanabe T, Kitani A, Murray PJ et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800-808.
46. Hollenbach E, Vieth M, Roessner A et al. Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J Biol Chem 2005; 280: 14981-14988.
47. Davies SJ, Bryan J, Phillips L et al. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498-506.
48. Rots NY, Iavarone A, Bromleigh V et al. Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. Blood 1999; 93: 2721-2729.
49. Betjes MG, Tuk CW, Struijk DG et al. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 1993; 43: 641-648.
50. Pickering JG, Ford CM, Tang B et al. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Arterioscler Thromb Vasc Biol 1997; 17: 475-482.